FTSE 250 constituent Oxford Nanopore Technologies plc has released positive results for the first half of 2025 and seen a stark increase in its share price.
The University of Oxford spinout is looking to deliver a new generation of molecular sensing technology based on nanopores and expects revenue for the first half of the year to be up 28% on last year at £105m.
The technology is used in more than 125 countries to understand the biology of humans, plants, animals, bacteria, viruses and environments as well as to understand diseases such as cancer.
Growth was strongest across the company’s PromethION product range, up by approximately 59% year-on-year.
The firm says it is continuing to progress on its path to profitability, reducing adjusted EBITDA loss and experiencing gross profit growth.
Since trading reopened today, it has seen its share price spike significantly, with the company being by far and away the biggest winner on the FTSE 250.
Its shares have increased from 145.8p at the close of play on Friday to 176.02p as of 9:02am on Monday – a stark 21% rise.
Its market cap currently sits at £1.69bn and the business says it has approximately £337m in cash, cash equivalents and other liquid investments.
It reflects a strong start to the year for Oxford Nanopore, which was one of the only London Stock Exchange giants to see its share price rise in the week following Donald Trump’s ‘Liberation Day’ tariffs announcement.
Growth is further shown when comparing the firm’s share price to the start of 2025, when it sat at 128.4p.